Reverse-phase high performance liquid chromatography for the determination of tiopronin in human plasma after derivatization with p-bromophenacyl bromide

被引:34
作者
Huang, TM [1 ]
Yang, B [1 ]
Yu, YJ [1 ]
Zheng, XW [1 ]
Duan, GL [1 ]
机构
[1] Fudan Univ, Sch Pharm, Dept Pharmaceut Anal, Shanghai 200032, Peoples R China
关键词
tiopronin (TP); reverse-phase high performance liquid chromatography (HPLC); derivatization; p-bromophenacyl bromide (p-BPB);
D O I
10.1016/j.aca.2006.02.049
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
In the study, we developed a simple, rapid and sensitive method for the determination of tiopronin (TP) in human plasma, which was based on derivatization with p-bromophenacyl bromide (p-BPB) followed by liquid-liquid extraction and reverse-phase HPLC-UV detection. For the first time, the p-BPB was introduced into the derivatization of TP. The thiol group of TP was trapped with p-BPB to form a TP-p-BPB adduct, which can be very suitable for UV detection. From acidified plasma samples, the derivatized TP was extracted with 5 mL dichloromethane. Effective chromatographic separation was achieved using a C 18 column (DIAMONSIL 150 mm x 4 mm i.d., 5 mu m) based on an acetonitrile-water-trifluoroacetic acid (40:59.88:0.12, v/v/v) elution at a flow-rate of 1 mL/min. The IS and the derivatized TP were detected at 263 nm. No endogenous substances were found to interfere. The limit of quantification for derivatized TP (TP-p-BPB) in plasma was 40 ng/mL. The calibration curve for the derivatized TP showed linearity in the range 0.04-4 mu g/mL with a regression coefficient corresponding to 0.9991 and the coefficient of the variation of the points of the calibration curve being lower than 10%. Extraction recoveries of the derivatized TP in plasma were greater than 72%. The method was suitably validated and successfully applied to determination of TP in human plasma samples. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:178 / 182
页数:5
相关论文
共 24 条
[1]   Determination of captopril in human serum by high performance liquid chromatography using solid-phase extraction [J].
Bahmaei, M ;
Khosravi, A ;
Zamiri, C ;
Massoumi, A ;
Mahmoudian, M .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1997, 15 (08) :1181-1186
[2]   STEADY-STATE PHARMACOKINETICS OF 2-MERCAPTOPROPIONYLGLYCINE (TIOPRONIN) IN HEALTHY-VOLUNTEERS AND PATIENTS WITH CYSTINURIA [J].
CARLSSON, MS ;
DENNEBERG, T ;
EMANUELSSON, BM ;
KAGEDAL, B ;
LINDGREN, S .
DRUG INVESTIGATION, 1994, 7 (01) :41-51
[3]  
CAVINS JF, 1968, J BIOL CHEM, V243, P3357
[4]   1,1'-[ethenylidenebis(sulfonyl)]bis-benzene: A useful pre-chromatographic derivatization reagent for HPLC analyses of thiol drugs [J].
Cavrini, V ;
Gotti, R ;
Andrisano, V ;
Gatti, R .
CHROMATOGRAPHIA, 1996, 42 (9-10) :515-520
[5]  
Delecoeuillerie G, 1989, Rev Rhum Mal Osteoartic, V56, P38
[6]   PHARMACOKINETICS OF CAPTOPRIL IN HEALTHY-SUBJECTS AND IN PATIENTS WITH CARDIOVASCULAR-DISEASES [J].
DUCHIN, KL ;
MCKINSTRY, DN ;
COHEN, AI ;
MIGDALOF, BH .
CLINICAL PHARMACOKINETICS, 1988, 14 (04) :241-259
[7]   High-performance liquid chromatography assay for N-acetylcysteine in biological samples following derivatization with N-(1-pyrenyl)maleimide [J].
Ercal, N ;
Oztezcan, S ;
Hammond, TC ;
Matthews, RH ;
Spitz, DR .
JOURNAL OF CHROMATOGRAPHY B-BIOMEDICAL APPLICATIONS, 1996, 685 (02) :329-334
[8]  
FERRACCIOLI GF, 1986, CLIN EXP RHEUMATOL, V4, P9
[9]   THE PHARMACOKINETICS OF TIOPRONIN AND ITS PRINCIPAL METABOLITE (2-MERCAPTOPROPIONIC ACID) AFTER ORAL-ADMINISTRATION TO HEALTHY-VOLUNTEERS [J].
HERCELIN, B ;
LEROY, P ;
NICOLAS, A ;
GAVRILOFF, C ;
CHASSARD, D ;
THEBAULT, JJ ;
REVEILLAUD, MT ;
SALLES, MF ;
NETTER, P .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1992, 43 (01) :93-95
[10]  
HUANG TM, 2006, J PHARM BIOMED 0112